TW200642681A - Medical composition for treating respiratory allergic disease - Google Patents
Medical composition for treating respiratory allergic diseaseInfo
- Publication number
- TW200642681A TW200642681A TW094119802A TW94119802A TW200642681A TW 200642681 A TW200642681 A TW 200642681A TW 094119802 A TW094119802 A TW 094119802A TW 94119802 A TW94119802 A TW 94119802A TW 200642681 A TW200642681 A TW 200642681A
- Authority
- TW
- Taiwan
- Prior art keywords
- medical composition
- allergic disease
- treating respiratory
- respiratory allergic
- inflammation
- Prior art date
Links
- 230000000241 respiratory effect Effects 0.000 title abstract 3
- 208000026935 allergic disease Diseases 0.000 title abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 2
- WWVKQTNONPWVEL-UHFFFAOYSA-N caffeic acid phenethyl ester Natural products C1=C(O)C(O)=CC=C1C=CC(=O)OCC1=CC=CC=C1 WWVKQTNONPWVEL-UHFFFAOYSA-N 0.000 abstract 2
- SWUARLUWKZWEBQ-VQHVLOKHSA-N phenethyl caffeate Chemical compound C1=C(O)C(O)=CC=C1\C=C\C(=O)OCCC1=CC=CC=C1 SWUARLUWKZWEBQ-VQHVLOKHSA-N 0.000 abstract 2
- SWUARLUWKZWEBQ-UHFFFAOYSA-N phenylethyl ester of caffeic acid Natural products C1=C(O)C(O)=CC=C1C=CC(=O)OCCC1=CC=CC=C1 SWUARLUWKZWEBQ-UHFFFAOYSA-N 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
Abstract
The present invention provides a medical composition for treating respiratory allergic disease. An active ingredient of the medical composition comprises caffeic acid phenethyl ester (CAPE) improving conditions of respiratory inflammation syndrome by its anti-inflammation effect.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW94119802A TWI281859B (en) | 2005-06-15 | 2005-06-15 | Medical composition for treating respiratory allergic disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW94119802A TWI281859B (en) | 2005-06-15 | 2005-06-15 | Medical composition for treating respiratory allergic disease |
Publications (2)
Publication Number | Publication Date |
---|---|
TW200642681A true TW200642681A (en) | 2006-12-16 |
TWI281859B TWI281859B (en) | 2007-06-01 |
Family
ID=38777544
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW94119802A TWI281859B (en) | 2005-06-15 | 2005-06-15 | Medical composition for treating respiratory allergic disease |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWI281859B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114524874A (en) * | 2022-03-04 | 2022-05-24 | 广东医科大学 | Method for reducing ovalbumin allergy by laccase/caffeic acid crosslinking and galactomannan combination |
-
2005
- 2005-06-15 TW TW94119802A patent/TWI281859B/en not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114524874A (en) * | 2022-03-04 | 2022-05-24 | 广东医科大学 | Method for reducing ovalbumin allergy by laccase/caffeic acid crosslinking and galactomannan combination |
CN114524874B (en) * | 2022-03-04 | 2023-08-11 | 广东医科大学 | Laccase/caffeic acid cross-linking and galactomannan combined method for reducing ovalbumin allergy |
Also Published As
Publication number | Publication date |
---|---|
TWI281859B (en) | 2007-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2018201997B2 (en) | Peptides which inhibit activated receptors and their use in cosmetic or pharmaceutical compositions | |
ATE417610T1 (en) | COMPOSITION CONTAINING 6-Ä3-(1-ADAMANTYL)-4-METHOXYPHENYLÜ-2-NAPHTHANOIC ACID FOR THE TREATMENT OF DERMATOLOGICAL DISEASES | |
MX366175B (en) | Concentrated therapeutic phospholipid compositions. | |
IN2012DN00639A (en) | ||
IL195030A (en) | Dpp iv inhibitor formulations | |
ATE495743T1 (en) | TRIAZOLOPYRIDINE COMPOUNDS FOR THE TREATMENT OF DEGENERATIONAL AND INFLAMMATORY DISEASES | |
MX2012012225A (en) | Nitric oxide releasing prodrugs of therapeutic agents. | |
UA110013C2 (en) | APPLICATION OF THE COMPOSITION FOR THE TREATMENT OF BALL-MARI-HERE AND THE RELATED DISORDERS | |
WO2009111700A3 (en) | Oxadiazoanthracene compounds for the treatment of diabetes | |
AU2007257423A8 (en) | Purine analogs | |
CY1113449T1 (en) | ANTI-VISUAL COMPOSITIONS CONTAINING GERANIOL AND CARBON | |
JO2973B1 (en) | Fumarate Salt Of (alphaS, betaR)-6-Bromo-alfa-[2-(dimethylamino)ethyl]-2- Methoxy-alpha-1-naphthalenyl-beta-phenyl-3- Quinolineethanol | |
WO2007138466A3 (en) | Pharmaceutical compositions comprising meloxicam and tramadol combination | |
BR112013026257A2 (en) | glycoside derivatives and uses thereof for the treatment of diabetes | |
WO2012006298A3 (en) | Formulation for co-therapy treatment of diabetes | |
SG178975A1 (en) | Indenone derivative and pharmaceutical composition comprising same | |
EP2361083A4 (en) | Composition for treatment of epithelial tissue | |
WO2008008882A3 (en) | Glucocorticoid receptor modulator and methods of use | |
EA201270747A1 (en) | COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF THE RAS | |
MX2013002649A (en) | Therapeutic agent for pain. | |
EA201070898A1 (en) | NEW HINAZOLIN-2,4-DIONA DERIVATIVE AND MEDICINAL COMPOSITIONS ON ITS BASIS FOR PREVENTION AND TREATMENT OF THE DISEASE, CAUSED BY DAMAGE OF THE CRANIAL NERVE | |
TW200642681A (en) | Medical composition for treating respiratory allergic disease | |
MX2009006212A (en) | Use of nepafenac or derivatives thereof for treating dermatological disorders linked with a keratinisation disorder that may include an inflammatory immuno-allergic component. | |
HN2007000505A (en) | PIRAZOL ANALOGS | |
BR112013000296A2 (en) | therapeutic agents 976 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |